2G5-22940-67433

4 vaccinations 8 coded responses 26 check-ins 8 free-text entries 3 call cases

Sex: Female
Age at first dose: 66+
ZIP prefix: 875 / NM
Registered: 2021-01-06

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-06
Registered in v-safe
2021-01-06
Dose 1 — Pfizer-BioNTech
2021-01-06
Health check-in — day 0, dose 1
Feeling: Fair · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-01-06
Report sent to call center — day 0, dose 1
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-07
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-08
Survey response — days 1–6 daily, dose 1
MedDRA: Muscular weakness — Feeling: Fair · Muscle or body aches

Free text: Episode of weak rubbery sensation in lower legs lasting about 2 hours very unusual

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-09
Survey response — days 1–6 daily, dose 1
MedDRA: Condition aggravated — Feeling: Fair

Free text: Worsening of underlying gerd

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-10
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-12
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-15
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-21
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-26
Dose 2 — Pfizer-BioNTech
2021-01-27
Survey response — days 1–6 daily, dose 2
MedDRA: Muscular weakness — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness

Free text: Muscle weakness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-28
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-29
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-31
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Joint pains, Muscle or body aches

Adult check-in
2021-02-01
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-02-04
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-02-09
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-16
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-23
Survey response — day 28, dose 2
MedDRA: Abdominal pain, Fatigue — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities

Free text: Fatigue and rly abdominal cramping for 24 hours

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-02
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-09
Survey response — day 42, dose 2
MedDRA: Dizziness, Nausea, Presyncope — Feeling: Good · Be unable to work, Be unable to do your normal daily activities

Free text: Had a near fainting episode late afternoon possibly related to low fluid intake. Became very nauseated, faint and dizzy had to lie on floor for 5 minutes or more and then 1 to 2 hours to recover never had an episode like this ever before

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-27
Survey response — 3 months, dose 2
MedDRA: Chest pain, Gastrooesophageal reflux disease, Musculoskeletal disorder — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Intermittent chest pain with GI symptoms of reflux symptoms mimicked a heart attack but were more musculoskeletal and also refux

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-27
Report sent to call center — 3 months, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-08
Call 1 — Left Voicemail
2021-07-27
Survey response — 6 months, dose 2
MedDRA: Chest pain, Gastric disorder — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Continued gastric problems and left sided chest pain

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-07-27
Report sent to call center — 6 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-08-03
Call 1 — Left Voicemail
2021-12-14
Dose 3 — Pfizer-BioNTech
2022-01-28
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in
2022-10-09
Dose 4 — Pfizer-BioNTech
2022-10-18
Health check-in — day 7, dose 4
Feeling: Good · None

Adult check-in
2022-10-30
Survey response — day 21, dose 4
MedDRA: Adverse reaction, Eye pruritus, Rhinorrhoea — Feeling: Good

Free text: Allergic symptoms itchy eyes, clear runny nose

MedDRA releases: 2024-11 · check-in free text available
2022-11-15
Health check-in — day 35, dose 4
Feeling: Good

Adult check-in
2023-01-08
Health check-in — 3 months, dose 4
Feeling: Fair

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-06	Pfizer-BioNTech
2	2021-01-26	Pfizer-BioNTech
3	2021-12-14	Pfizer-BioNTech	No
4	2022-10-09	Pfizer-BioNTech	No

Call center

3 call center cases

2 unsuccessful · 1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2021-01-08

Systemic reaction (other): Episode of weak rubbery sensation in lower legs lasting about 2 hours very unusual

2021-01-09

Systemic reaction (other): Worsening of underlying gerd

Release 2 — days 1–6 daily, dose 2

2021-01-27

Systemic reaction (other): Muscle weakness

Release 4 — day 28, dose 2

2021-02-23

Symptoms: Fatigue and rly abdominal cramping for 24 hours

Release 5 — day 42, dose 2

2021-03-09

Symptoms: Had a near fainting episode late afternoon possibly related to low fluid intake. Became very nauseated, faint and dizzy had to lie on floor for 5 minutes or more and then 1 to 2 hours to recover never had an episode like this ever before

Release 8 — 3 months, dose 2

2021-04-27

Symptoms: Intermittent chest pain with GI symptoms of reflux symptoms mimicked a heart attack but were more musculoskeletal and also refux

Release 9 — 6 months, dose 2

2021-07-27

Symptoms: Continued gastric problems and left sided chest pain

Release 12 — day 21, dose 4

2022-10-30

Symptoms: Allergic symptoms itchy eyes, clear runny nose

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Abdominal pain	✓	✓	✓
SD	Adverse reaction	·	·	✓
SD	Chest pain	✓	✓	✓
SD	Dizziness	✓	✓	✓
SD	Eye pruritus	·	·	✓
SD	Fatigue	✓	✓	✓
SD	Gastric disorder	✓	·	✓
SD	Gastrooesophageal reflux disease	✓	✓	✓
SD	Musculoskeletal disorder	✓	✓	✓
SD	Nausea	✓	✓	✓
SD	Presyncope	✓	✓	✓
SD	Rhinorrhoea	·	·	✓
SRO	Condition aggravated	✓	✓	✓
SRO	Muscular weakness	✓	✓	✓
SRO	Rubber sensitivity	○	○	○

✓ active code · ○ coded but marked inactive · blank = not in that release